Matches in SemOpenAlex for { <https://semopenalex.org/work/W96119478> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W96119478 endingPage "87" @default.
- W96119478 startingPage "75" @default.
- W96119478 abstract "espanolLa anticoncepcion hormonal constituye el segundo metodo anticonceptivo mas utilizado en nuestro pais. Las principales novedades en cuanto a composicion son la introduccion del valerato de estradiol como componente estrogenico para mejorar la seguridad y de la drospirenona, progestageno con accion antimineralocorticoide, que contrarresta la retencion hidrosalina y ha sido aprobado como tratamiento del sindrome premenstrual. Para mejorar el cumplimiento se han propuesto el metodo de inicio inmediato y los regimenes de administracion en ciclo prolon gado o continuo que disminuyen los sintomas del periodo libre de hormona. La via transdermica presenta niveles sericos superiores de etinilestradiol que la oral lo que puede elevar el riesgo de tromboembolismo. Las innovaciones en la anticoncepcion de emergencia son la pauta toma unica de 1500 mcg de levonorgestrel y su dispensacion sin receta. En este trabajo se revisan tambien los riesgos asi como los criterios medicos de elegibilidad de la anticoncepcion hormonal EnglishThe second more frequently used contraception method in our country is hormonal contraception. Innovations in composition include the introduction of estradiol valerate as estrogen element to improve safety, and oral contraceptives containing drospirenone that is a progestin with antimineraolcorticoid activity and has been approved for treating premenstrual syndrome. To improve compliance quick start and extended dose regimen, that decreases symptoms during hormonal free interval, have been proposed. With transdermal patch ethinylestradiol serum level is higher than with oral contraceptives therefore venous thromboembolism risk can be increased. Main innovations in emergency contraception are the 1500 mcg single dose of levonorgestrel regimen and the possibility of obtaining it without medical prescription. In this essay we also review severe adverse effects and medical eligibility criteria of hormonal contraception." @default.
- W96119478 created "2016-06-24" @default.
- W96119478 creator A5002703172 @default.
- W96119478 creator A5051294520 @default.
- W96119478 creator A5087336551 @default.
- W96119478 date "2011-01-01" @default.
- W96119478 modified "2023-09-23" @default.
- W96119478 title "Actualización en anticoncepción hormonal" @default.
- W96119478 cites W122047940 @default.
- W96119478 cites W149410151 @default.
- W96119478 cites W1974373346 @default.
- W96119478 cites W1979064847 @default.
- W96119478 cites W1983554558 @default.
- W96119478 cites W2019908859 @default.
- W96119478 cites W2033054044 @default.
- W96119478 cites W2043161810 @default.
- W96119478 cites W2044769668 @default.
- W96119478 cites W2065985324 @default.
- W96119478 cites W2087110660 @default.
- W96119478 cites W2111709107 @default.
- W96119478 cites W2121453708 @default.
- W96119478 cites W2413981935 @default.
- W96119478 cites W1991174173 @default.
- W96119478 hasPublicationYear "2011" @default.
- W96119478 type Work @default.
- W96119478 sameAs 96119478 @default.
- W96119478 citedByCount "7" @default.
- W96119478 countsByYear W961194782013 @default.
- W96119478 countsByYear W961194782014 @default.
- W96119478 countsByYear W961194782016 @default.
- W96119478 countsByYear W961194782020 @default.
- W96119478 crossrefType "journal-article" @default.
- W96119478 hasAuthorship W96119478A5002703172 @default.
- W96119478 hasAuthorship W96119478A5051294520 @default.
- W96119478 hasAuthorship W96119478A5087336551 @default.
- W96119478 hasConcept C126322002 @default.
- W96119478 hasConcept C142362112 @default.
- W96119478 hasConcept C15708023 @default.
- W96119478 hasConcept C2776172332 @default.
- W96119478 hasConcept C2776607906 @default.
- W96119478 hasConcept C2778001906 @default.
- W96119478 hasConcept C2779076696 @default.
- W96119478 hasConcept C2779522080 @default.
- W96119478 hasConcept C2780186607 @default.
- W96119478 hasConcept C2780330700 @default.
- W96119478 hasConcept C2781418897 @default.
- W96119478 hasConcept C2908647359 @default.
- W96119478 hasConcept C29456083 @default.
- W96119478 hasConcept C2986817661 @default.
- W96119478 hasConcept C71315377 @default.
- W96119478 hasConcept C71924100 @default.
- W96119478 hasConcept C99454951 @default.
- W96119478 hasConceptScore W96119478C126322002 @default.
- W96119478 hasConceptScore W96119478C142362112 @default.
- W96119478 hasConceptScore W96119478C15708023 @default.
- W96119478 hasConceptScore W96119478C2776172332 @default.
- W96119478 hasConceptScore W96119478C2776607906 @default.
- W96119478 hasConceptScore W96119478C2778001906 @default.
- W96119478 hasConceptScore W96119478C2779076696 @default.
- W96119478 hasConceptScore W96119478C2779522080 @default.
- W96119478 hasConceptScore W96119478C2780186607 @default.
- W96119478 hasConceptScore W96119478C2780330700 @default.
- W96119478 hasConceptScore W96119478C2781418897 @default.
- W96119478 hasConceptScore W96119478C2908647359 @default.
- W96119478 hasConceptScore W96119478C29456083 @default.
- W96119478 hasConceptScore W96119478C2986817661 @default.
- W96119478 hasConceptScore W96119478C71315377 @default.
- W96119478 hasConceptScore W96119478C71924100 @default.
- W96119478 hasConceptScore W96119478C99454951 @default.
- W96119478 hasIssue "3" @default.
- W96119478 hasLocation W961194781 @default.
- W96119478 hasOpenAccess W96119478 @default.
- W96119478 hasPrimaryLocation W961194781 @default.
- W96119478 hasVolume "35" @default.
- W96119478 isParatext "false" @default.
- W96119478 isRetracted "false" @default.
- W96119478 magId "96119478" @default.
- W96119478 workType "article" @default.